Profile
George Gilbert Cloyd is currently the CEO of Ofgcgi and a board member at Research Bridge Partners.
He previously worked as the Chairman of The Ohio State University, Lumos Pharma Sub, Inc., and Chief Technology Officer at Procter & Gamble Co. He earned a doctorate degree from The Ohio State University in 1969.
George Cloyd active positions
| Companies | Position | Start |
|---|---|---|
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Director/Board Member | 01/01/2017 |
Ofgcgi | Chief Executive Officer | 01/10/2015 |
Former positions of George Cloyd
| Companies | Position | End |
|---|---|---|
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Chairman | 01/01/2009 |
| PROCTER & GAMBLE COMPANY | Chief Tech/Sci/R&D Officer | 01/09/2008 |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Chairman | - |
Training of George Cloyd
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Procter & Gamble Co.
Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Health Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Finance |
Ofgcgi |
- Stock Market
- Insiders
- George Cloyd
















